Log on / register
Feedback | Support | My details
A meta-analysis of N-acetylcysteine in contrast-induced nephrotoxicity: unsupervised clustering to resolve heterogeneity.
Gonzales DA, Norsworthy KJ, Kern SJ, Banks S, Sieving PC, Star RA, Natanson C, Danner RL
BMC Med 2007, 5:32
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

BioMed Central articles that cite the above article:

1.


Research    
N-acetylcysteine does not prevent contrast-induced nephropathy after cardiac catheterization in patients with diabetes mellitus and chronic kidney disease: a randomized clinical trial
Amini M, Salarifar M, Amirbaigloo A, Masoudkabir F, Esfahani F
Trials 2009, 10:45 (29 June 2009)
 [Abstract] [Full Text] [PDF] [PubMed] [Related articles]
2.


Study protocol    
Rationale, design, and baseline characteristics of the Acetylcystein for Contrast-Induced nephropaThy (ACT) Trial: a pragmatic randomized controlled trial to evaluate the efficacy of acetylcysteine for the prevention of contrast-induced nephropathy
The ACT Trial Investigators
Trials 2009, 10:38 (4 June 2009)
 [Abstract] [Full Text] [PDF] [PubMed] [Related articles]
3.


Commentary    
Preventing contrast-induced nephropathy: problems, challenges and future directions
Solomon R
BMC Medicine 2009, 7:24 (13 May 2009)
 [Abstract] [Full text] [PDF] [PubMed] [Related articles]

This article is also cited by a further 1 article in PubMed Central


You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.